US Patent 9382567 Methods of producing hybrid antibodies
Patent 9382567 was granted and assigned to Regeneron Pharmaceuticals on July, 2016 by the United States Patent and Trademark Office.
Is a
Current Assignee
Date Filed
September 25, 2013
Date of Patent
July 5, 2016
Patent Applicant
Patent Application Number
14036530
Patent Jurisdiction
Patent Number
Patent Primary Examiner
Find more entities like US Patent 9382567 Methods of producing hybrid antibodies
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
